Degradable molecularly imprinted polymers (MIPs) with affinity for S-propranolol were prepared by the copolymerization of methacrylic acid as functional monomer and a disulfide-containing cross-linker, bis(2-methacryloyloxyethyl)disulfide (DSDMA), using bulk polymerization or high dilution polymerization for nanogels synthesis. The specificity and the selectivity of DSDMA-based molecularly imprinted polymers toward S-propranolol were studied in batch binding experiments, and their binding properties were compared to a traditional ethylene glycol dimethacrylate (EDMA)-based MIP. Nanosized MIPs prepared with DSDMA as crosslinker could be degraded into lower molecular weight linear polymers by cleaving the disulfide bonds and thus reversing cross-linking using different reducing agents (NaBH 4 , DTT, GSH). Turbidity, viscosity, polymer size and IR-spectra were measured to study the polymer degradation. The loss of specific recognition and binding capacity of S-propranolol was also observed after MIP degradation. This phenomenon was applied to modulate the release properties of the MIP. In presence of GSH at its intracellular concentration, the S-propranolol release was higher, showing that these materials could potentially be applied as intracellular controlled drug delivery system. a Abbreviation C m , monomer concentration calculated as the mass ratio of functional monomer and cross-linker to the total mass of polymer formulation. b Imprinting factor determined for a polymer concentration of 0.08 g L À1 . c Imprinting factor determined for a polymer concentration of 0.8 g L À1 .
Introduction
During the recent decades, stimuli-responsiveness has been playing an increasingly important role in materials development for a diverse range of biological applications. [1] [2] [3] [4] [5] Among the most extensively explored applications is smart drug delivery, for intracellular gene delivery systems or for small anti-cancer molecules, where their capacity of responding to a variation of the cellular environment or physiological conditions can advantageously be used to specically trigger the drug release. [6] [7] [8] [9] [10] Especially, disuldebased polymers and conjugates have recently attracted considerable interest as effective delivery vehicles, as proven by the many papers and reviews focusing on reduction-sensitive polymers and their possible application in the biomedical eld. 11 Reduction sensitivity of materials containing disulde bonds has been exploited to develop specic intracellular drug delivery systems for various therapeutic agents such as anti-cancer drugs, peptides, proteins, siRNA, DNA, that require to be delivered inside the cell to exert their therapeutic effects.
Indeed, the disulde bonds can be converted into thiol groups under reductive environment. This results in carrier degradation and the subsequent release of the encapsulated molecules. The material degradation also facilitates the carrier removal aer drug release. 12 As the intracellular concentration of glutathione (GSH, 1-10 mM), a biological reductive peptide, is 100 to 1000 times higher than its level in extracellular environment (20-40 mM), 13 disulde reductive reactions can occur only aer cell internalization of the materials. A stable delivery system outside the cell can thus be provided in contrast to other systems such as pH-responsive or hydrolysable polymers that can be degraded in the blood circulation or in the extracellular matrix. Furthermore, disulde-based materials could also be applied for the development of anti-cancer drug delivery systems, due to the higher GSH concentration in cancer cells and the abnormal physiological conditions of the cancerous or inamed tissues. 14 Micro/nano gels are oen preferred for biomedical applications, owing to their tunable size, their internal cross-linked network for the incorporation of payload molecules, and a large specic surface area for modication. Microgels incorporating disulde bonds in the polymer backbone were synthesized by several polymerization methods 15 and with the use of appropriate disulde-functionalized initiators, 16 monomers or cross-linkers. 17 Especially, gels containing disulde functionalized dimethacrylate cross-linkers such as DSDMA have been widely synthesized by copolymerization with different monomers. They have been applied for DNA, anticancer drug, uorescent dye delivery, 18 for self healing materials 19 or scaffolds. 20 Selective reduction of the disulde groups in DSDMA cross-linked copolymers with phosphine or thiolcontaining molecules leads to the cleavage of the intermolecular branching and to the formation of low molecular weight polymer chains inducing dissolution or swelling of the gel.
Molecularly imprinted polymers (MIPs) are biomimetic synthetic receptors that possess the most important feature of natural receptors like antibodiesthe ability to recognize and bind a target molecule. 21 MIPs are generally synthesized by thermo-or light-initiated radical polymerization, wherein a selfassembled complex is formed through non-covalent interactions between the functional monomer(s) and a template, the target molecule or a derivative, which is then co-polymerized with a cross-linker. Aer template removal from the polymer, specic cavities, which are complementary in both shape and chemical functionality to the template molecule, are formed. Due to their high affinity and selectivity, MIPs are widely used in affinity technology, in the food, environment and biomedical domains, reviewed elsewhere. 22 MIPs also emerged recently in the biomedical eld for cell and tissue imaging 23 or as controlled delivery systems for bio-active substances. 24 In the latter application, the high affinity between polymers and template leads to a sustained drug delivery, controlled release sometimes depending on the surrounding environment. Few works reported the synthesis of stimuli-responsive MIPs; they were either sensitive to pH, light 25 or temperature. 26 Design of multifunctional materials both targeting a tissue or cells and capable of controlling the drug delivery, are highly relevant to increase the pharmaceuticals efficiency. Although, MIP are promising drug delivery system, their application as pharmaceuticals is still at its early stage compared to some other traditional formulations. Indeed, highly relevant aspects of materials designed for medical sciences such as biocompatibility, cytotoxicity, bioavailability, behavior in biological environment (in vivo experiments) have been little studied or were not considered at all for MIPs, thus hampering their development in this eld. 27 In the emerging application of MIPs in biomedical eld, redox-sensitive MIP are highly interesting as carriers targeting a specic cell or tissue or for intracellular drug delivery by responding to a biological environment change. In addition, the degradation of the MIP matrix could improve the biocompatibility of this carrier.
In the present work, we have synthesized reduction-sensitive molecularly imprinted polymers by using a cross-linker containing a disulde group such as bis(2-methacryloyloxyethyl) disulde (DSDMA) or N,N 0 -bis(acryloyl)cystamine (BAC), which can be cleaved in reductive media (Scheme 1). These crosslinkers are not used traditionally for MIP synthesis. As the cross-linker represents usually 80% of the MIP composition, the nature of the cross-linker thus has a strong effect on the structure and binding properties of MIP. Molecular imprinting with unusual cross-linkers is thus challenging. S-Propranolol, a beta-blocker used especially in cardiac disorders, has been selected as a model template for this study. Indeed, S-propanol is being employed frequently as template to develop new MIP systems. 28 S-Propranolol MIPs were obtained both in bulk format and as nanogels by high dilution polymerization. Further, we studied and characterized the MIPs' degradation in the presence of different reducing agents (NaBH 4 , DTT, GSH) and the effect of this treatment on the binding properties and release of S-propranolol to demonstrate that the degradation triggers controllable release of encapsulated molecules.
Experimental part

Materials
All chemicals and solvents were of analytical grade and purchased from Sigma-Aldrich, unless stated otherwise. 2,2 0 -Azobis(2,4-dimethyl)valeronitrile (ABDV) was obtained from DuPont Chemicals (Wilmington, USA). [ 3 H]-S-Propranolol (23.2 Ci mmol À1 ) was from Sigma. S-Propranolol hydrochloride was converted into the free base by extraction from a sodium carbonate solution at pH 9 with chloroform.
Synthesis of reduction-responsive MIPs
Molecularly imprinted micro-and nanoparticles were synthesized by bulk or high dilution polymerization, respectively, under the conditions described in Table 1 . In a typical procedure, the template molecule (S-propranolol) was dissolved in acetonitrile or DMSO in a vial sealed with a silicon rubber septum. DMSO was used as solvent for nanogel synthesis to produce homogenous nanoparticles. The polymerization initiator (ABDV), the functional monomer (MAA) and the crosslinking monomer (EDMA, DSDMA or BAC) were added with a 1 : 0.88 : 8 : 40 molar ratio to the template, respectively. The solution was purged with a gentle ow of nitrogen for 10 min. Polymerization was carried out in a water bath at 50 C for 24 hours for bulk polymerization or 4 days for nanogels. Aer polymerization, bulk polymers were crushed and ground in a mortar. To remove the template and any unreacted monomers, bulk polymers were washed by incubation-centrifugation cycles in methanol/acetic acid 9 : 1 mixtures (4Â) and methanol (3Â). Nanogels were dialyzed against water/acetic acid 19 : 1 mixtures (3Â) followed by water (3Â) and collected by freezedrying. Non-imprinted control polymers (NIP) were synthesized in the same way but in the absence of the template Spropranolol.
Characterization
Morphology. Transmission electron microscopy (TEM) images were obtained on a Hitachi H-600 microscope with an accelerating voltage of 100 kV. The samples were prepared by depositing a drop of nanogel solution (0.05 g L À1 ) in ethanol onto a copper grid with carbon lm 200 mesh Cu (50) (Agar Scientic), followed by drying off the solvent in air before analysis. Scanning electron microscopy (SEM) images were done on a Philips XL30 ESEM. For the sample preparation, a drop of polymer solution in ethanol at 0.05 g L À1 was deposited on a cleaned glass surface and dried in air before vapordeposition of a few nm of gold.
Particle size measurements. The hydrodynamic diameter of nanogels was determined by dynamic light scattering at 25 C using a Zetasizer Nano ZS (ZEN 3600, Malvern Instruments Ltd) with a laser of 4 mW (He-Ne, l ¼ 632 nm, 173 , backscatter). The samples were prepared in acetonitrile (0.1 g L À1 of polymer) and sonicated in an ultrasonic bath for 15 min until no particle aggregates could be observed, and measured with automatic run time.
Turbidimetry. A Hitachi U3300 UV/Vis spectrophotometer was used to measure the turbidity of nanogels solutions at 600 nm.
Fourier-transform infrared spectroscopy (FTIR). FTIR spectra (4000-800 cm À1 , 4 cm À1 resolution, 500 scans) were measured using a Thermo Nicolet 6700 FTIR spectrometer equipped with a ZnSe ATR (attenuated total reectance) system and MCT-B detector.
Viscosimetry. Polymer stock suspensions of 10 g L À1 with or without reducing agents (20 mM DTT) were prepared in Tris-HCl buffer (0.1 M, pH 8.0). These stock suspensions were diluted to obtained serial polymer dilutions from 1 g L À1 to 10 g L À1 . The viscosity of each polymer suspension was measured in triplicate at 30 C using a calibrated "Micro Ostwald" capillary viscometer. The specic viscosity (h sp ) of the polymer suspension was calculated by the equation:
where h: viscosity of polymer suspension and h 0 : viscosity of solvent.
Size exclusion chromatography (SEC). Molecular weights of the reduction-sensitive nanogels before and aer degradation tests were determined by SEC using an Ultimate 300 HPLC (Dionex) equipped with a Shodex RI-101 Refractive Index (RI) detector, 1 Agilent PL gel 5 mm Guard column, 50 Â 7.5 mm and Scheme 1 Schematic representation of syntheses and reduction-induced degradation of S-propranolol molecularly imprinted polymers for drug delivery.
Table 1 Polymerization conditions
Polymer
Polymerization method
2 Agilent PL gel 5 mm MIXED-D columns, 2 Â 300 Â 7.5, with THF as mobile phase (ow 1 mL min À1 ) at 25 C. Samples (4 g L À1 ) were extracted with chloroform (3Â) and dried under N 2 ow. The residue was then dissolved in THF and subjected to SEC. Molecular weights were determined by data analysis (soware: Chromeleon 6.8 Chromatography Data System) on the basis of a calibration curve obtained from polymethylmethacrylate standards. Langmuir binding isotherms were recorded to determine the dissociation constant (K d ) and maximum binding capacity (B max ). The polymer at a xed concentration of 0.1 g L À1 was incubated with 0.6 pmol [ 3 H]-S-propranolol and S-propranolol with a concentration ranging from 0.171 mM to 60 mM in acetonitrile. Binding isotherms were then tted with the Langmuir model according to the following equation:
Evaluation of MIPs binding properties
where F and B represent equilibrium concentrations of Spropranolol in the liquid phase and in the adsorbed phase, respectively.
To evaluate the selectivity of the bulk MIP, competitive binding assays with the two enantiomers of propranolol were performed to determine their IC 50 . 0.1 g L À1 polymer were incubated with 0.6 pmol [ 3 H]-S-propranolol and with varying concentrations (from 2 pM to 0.2 mM) of S-propranolol or Rpropranolol as competitors in anhydrous acetonitrile. The cross-reactivity is dened as the IC 50 ratio of the two enantiomers:
Degradation tests of nanogels
The degradation tests of nanogels were performed both in organic and aqueous media according to the reducing agent.
For the test in organic media, a 1 g L À1 solution of polymer nanogels cross-linked with DSDMA was prepared in DMSO, then 50 mM NaBH 4 was added. The reaction was allowed to proceed for 5 min where aer the unreacted NaBH 4 was inactivated by adding 10 mL of 2 mM HCl. To determine the size of the polymer particles aer degradation, 50 mL polymer suspension was withdrawn and mixed with 950 mL ethanol to adjust the nal concentration to 0.05 g L À1 , then one drop was deposited on a glass substrate and dried under N 2 ow prior to SEM measurements. The polymer composition aer degradation was analyzed by FTIR. The degradation test in aqueous media was carried out using DTT or GSH as reducing agent instead of NaBH 4 . A DSDMA cross-linked nanogel solution (1 g L À1 ) was prepared in oxygenfree Tris-HCl buffer (100 mM, pH 8.0), DTT (20 or 40 mM) was added and reacted under nitrogen for 10 min at 37 C. Aer the degradation, the polymers were analyzed by dynamic light scattering, size exclusion chromatography and viscosimetry. For nanogel degradation by GSH, DSDMA-based nanogel solutions (1 g L À1 ) were mixed with GSH (20 mM) in oxygen-free sodium acetate buffer (100 mM, pH 5.0) during 14 hours. Control experiments were carried out in the same way but without GSH.
In vitro release of S-propranolol from nanogels S-Propranolol (2 mM) and MIPs or NIPs (1 g L À1 ) were incubated in anhydrous acetonitrile overnight with gentle agitation, then the particle suspension in acetonitrile was put in a dialysis tube and dialyzed against sodium acetate buffer (0.1 M, pH 5.0) to remove the unbound S-propranolol. The release study was carried out with or without the presence of GSH (10 mM) in sodium acetate buffer (0.1 M, pH 5.0) at 37 C. The concentration of the released S-propranolol was determined by spectro-uorimetry (Fluorolog, HORIBA) with excitation and emission wavelengths, respectively at 290 nm and 357 nm.
Results and discussion
Synthesis and characterization of reduction-sensitive MIPs
In the molecular imprinting eld, the functional monomer, cross-linker and solvent have to be carefully selected to obtain MIPs with highly specic and selective binding properties for a given target molecule. While the cross-linker is thought not to be directly involved in the interaction with the template (in fact it oen is), as a major component in the MIPs formulation it still plays a determining role for the MIP recognition properties. Indeed, the cross-linking monomer and degree have to be controlled to tune the polymer's inner morphology such as porosity, and polymeric chain exibility or matrix rigidity for good template accessibility to the binding sites and to nd an appropriate rigidity of the binding cavities allowing a high affinity for the template. 29 By introducing a cleavable bond in the cross-linker structure, the 3D-network could be degraded under the appropriate trigger into linear polymer chains, leading to an enhancement of the matrix exibility and subsequently to a loss of the molecular recognition properties. If MIPs are loaded with a target molecule as a cargo, the degradation of the polymer induced by a stimulus can provoke the release of the entrapped molecule. This feature can be especially relevant for applications as drug delivery systems. As shown in Scheme 1, we propose to apply this concept for the production of MIPs that can be degraded in a reductive environment by using a cleavable cross-linker containing a disulde bond and S-propranolol as model drug. The synthesis of reduction-sensitive molecularly imprinted polymers for S-propranolol was done using methacrylic acid as functional monomer and disulde-based cross-linker with the ratio 8 : 40 : 1 respectively to the template, as previously reported in the literature. 30 Two disulde-based cross-linkers, bis(2-methacryloyl)oxyethyl disulde (DSDMA) and N,N 0 -bis(acryloyl)cystamine (BAC) were tested in this study to replace the commonly used EDMA for MIP synthesis (Scheme 1). In addition, EDMA-based MIPs for S-propranolol imprinting were also prepared in the same manner as a control to study the effect of the reducing agent on morphological, structural and binding properties of the MIPs.
Disulde and EDMA-based MIP particles were synthesized in the form of bulk polymers and nanogels by different polymerization methods. Fig. 1 shows the SEM images of MIP particles obtained by bulk polymerization, as well as the TEM images and DLS analysis of MIP nanogels prepared by high dilution polymerization with different cross-linkers. Bulk polymer particles resulting from the grinding of monolithic materials present an irregular and rough morphology with a particles size greater than 1 mm, whereas nanoparticles were obtained by high dilution polymerization.
One can also observe a strong effect of the nature of the cross-linker on the polymer structure and porosity. Whereas the morphologies of EDMA and DSDMA-based polymers seem similar, the shape and surface rugosity of BAC-based polymers are very different with a cauliower-like structure. Although the binding properties of bulk polymers are easily evaluated, their irregular particle form and size hinders their applications in many domains. Therefore, we also synthesized smaller MIP nanogels with a diameter in the lower nm range. Radical polymerization in highly diluted solution is the simplest way to prepare nanogels, since no surfactants or other additives are required. 31 Polymerization yields for M4 and M1 synthesized by high dilution and bulk polymerization were 50% and 83%, respectively. The morphology of the DSDMA and EDMA nanogels are quite similar with a size (determined by DLS in DMSO) of around 30 nm.
Binding properties of reduction-sensitive MIPs
Aer template removal, MIP selectivity and specicity were studied by radioligand binding assays in acetonitrile using 3 Hlabeled S-propranolol. Binding isotherms were obtained by incubating varying concentrations of MIP and NIP prepared by bulk or high dilution polymerization with a constant amount of 3 H-labeled S-propranolol (Fig. 2) . For bulk polymers, the adsorption on DSDMA-MIP are higher than on EDMA-MIP with a better imprinting factor, whereas the non-imprinted control polymers have very low S-propranolol adsorption. BAC-MIP has a very low S-propranolol binding, probably resulting from the strong morphological difference compared to DSDMA-and EDMA-MIP. For nanogels, the same behavior can be observed with a higher imprinting factor for DSDMA-MIP than EDMA-MIP (2.4 compared to 1.4 for EDMA-MIP at a polymer concentration of 0.1 mg mL À1 ), but with a lower adsorption capacity than for bulk MIPs. Furthermore, the affinity and enantioselectivity of EDMA and DSDMA cross-linked MIPs have been assessed as shown in Table 2 . The dissociation constant (K d ) and maximum binding capacity (B max ) of S-propranolol were determined by tting the binding isotherms to a Langmuir model (see ESI Fig. S1 †) . Similar affinities and binding capacities were obtained for both materials. The enantioselectivity of the MIPs was then determined by competitive radioligand binding experiments. A xed amount of polymer was incubated with a xed amount of radiolabeled S-propranolol and increasing concentrations of competing ligand (Rpropranolol or S-propranolol) in anhydrous acetonitrile to obtain the competition curves for EDMA-or DSDMA-based MIPs (see ESI Fig. S1 †) and their corresponding crossactivities. The EDMA-based MIP shows an excellent enantioselectivity with a cross-reactivity of 1.4%, as previously reported. 30 The cross-reactivity of the R enantiomer is somewhat higher with the DSDMA-based MIP. However, the MIP is nevertheless highly specic and selective. This shows that DSDMA can be an interesting cross-linker alternative to EDMA for MIP synthesis.
Reductive cleavage of disulde-containing polymers
Effect of the reducing agent on bulk MIPs. Bulk polymers cross-linked by DSDMA or EDMA (negative control) were treated by NaBH 4 for 4 h. Aer thoroughly washing off all residual reducing agent and cleaved products, the bulk polymers were recovered by centrifugation. Aer determining the amount of free thiol groups formed, one can observe that the DSDMA MIP is not completely degraded. Only some 72% of the disulde bonds in the DSDMA-based polymer could be cleaved in the presence of NaBH 4 as determined by Ellman's reagent (see ESI Fig. S2 †) . Because of the compact structure of bulk polymers and their large particle size, it was expected that their degradation by a reducing agent would be slow and incomplete. The incomplete degradation of the DSDMA bulk polymer may also be explained by some unbreakable linkages formed by radical chain transfer to the disulde bond during the polymerization. 32 Chemical modications aer treatment with the reducing agent were observed by FTIR spectroscopy (Fig. 3 ). FTIR spectra of EDMA and DSDMA-based MIPs are very similar relating to their close chemical structures and contain all the characteristic bands that are present in FTIR spectra of MAA and crosslinkers. A number of characteristic peaks were observed at 2950 cm À1 (aliphatic CH 2 , CH, CH 3 groups), 1440 cm À1 (aliphatic CH 2 ), 1380 cm À1 , 1240 cm À1 , 1144 cm À1 (C-O) associates with the ethylene glycol unit. On the other hand, the strong bands at 1730 cm À1 and the weaker at 1650 cm À1 were assigned to C]O stretching vibration of the ester/acid group and C]C vibration band of the residual vinylic groups con-rming a successful co-polymerization of the cross-linkers with the functional monomer MAA. In the spectra of degraded materials, a new band at 2250 cm À1 , which corresponds to the presence of free thiol groups, is observed only for the DSDMA- based polymer indicating that the disulde bonds in this polymer have been successfully reduced by NaBH 4 . However, the EDMA-based polymer spectrum is also slightly modied aer its incubation with NaBH 4 . A decreased peak intensity of the C]O group is observed and a strong band at 3440 cm À1 corresponding to O-H stretching vibration appears. As suggested above for the reduction experiments with DSDMA, these modications have been attributed to a potential concomitant ester reduction by the strong reducing agent. Therefore, so reducing agents, namely DTT or GSH, described in the literature for their specic disulde bond reduction properties, were also evaluated for the degradation of nanogels.
Characterization of the nanogels degradation
By decreasing the particles size, a fully degradable system might be obtained. DSDMA-based nanogels were incubated in Trisbuffer (pH 8.0, 0.1 M) with DTT. As shown in Scheme 1 and Fig. 4A , the turbidity of DSDMA-based polymer solution decreases rapidly aer the addition of DTT and a transparent solution is obtained in less than one hour, due to the degradation of DSDMA-based nanogel into smaller more soluble polymeric chains. No modication of the size distribution and the turbidity was observed for EDMA-based polymer, which suggests that the EDMA cross-linker is not cleavable by DTT. The degradation of the nanogel under reductive environment was also demonstrated by the modication of the particles size characterized by DLS analysis, viscosimetry and SEC. DLS analysis of the hydrodynamic diameter of DSDMA-based nanogel (Fig. 4B ) aer incubation with DTT showed a large decrease in particles size from 615 nm to 295 nm, whereas EDMA-based particles are less affected. The nanoparticles have larger diameters in aqueous media than aer their synthesis, depending also on buffer composition. This is attributed to a different polymer swelling according to the solvent composition (pH, buffer nature) and the possible formation of nanogel clusters in aqueous media. The DSDMA-based nanogel degradation into smaller polymer chains is also conrmed by the difference of the specic viscosity of DSDMA-based polymer solutions in the presence of DTT (Fig. 4C) . Indeed, viscosity allows to estimate the molecular weight and the shape of a polymer. 33 The decrease in specic viscosity under reductive environment for DSDMA-based polymer solution can be attributed to a modication of the polymer molecular weight or to its structure. Finally, SEC analysis was performed to study the polymer molecular weight modication. Aer treatment with DTT, the reduced polymer was extracted with chloroform and analyzed by SEC. As shown in Fig. 4D , a noticeable difference in retention time was observed for DSDMA-based polymer incubated with different DTT concentrations indicating a decrease of the polymer molecular weight with a higher amount of reducing agent. Thus, the disulde links in the nanogels matrix can be cleaved in the presence of a so reducing agent inducing a degradation of the polymer network. The degradation of DSDMA cross-linked polymer was also examined under a physiological reducing environment using GSH as reducing agent at the intracellular concentration (10 mM) at 37 C. DLS analysis and turbidity (see ESI Fig. S3 †) showed a sharp decrease of polymer size from 955 nm to 255 nm and the solubilization of the polymer as with DTT aer 4 h incubation, suggesting that GSH can also degrade DSDMA-based nanogels by reducing the disulde bonds incorporated into the polymer.
Binding property change aer the reduction cleavage of the disulde bonds
Binding properties of DSDMA cross-linked bulk and nanogel MIPs were also investigated aer treatment with different reducing agents (NaBH 4 or DTT). A loss of their binding properties was observed for both MIP formats and reducing agents as shown in Fig. 5 . However, a stronger effect of the reducing agent on the S-propranolol binding properties have been obtained with nanogels than with bulk polymer with a binding decrease of 89% and 70%, respectively. This difference is more signicant when DTT was used as reducing agent. The binding loss was 75% for nanogel but only 14% for bulk polymer. With the NIPs, virtually no change in binding properties was observed aer the treatment with the reducing agents. This was expected since the non-specic binding to the NIP is much less dependent on the integrity of the 3D polymer network than the binding to the specic binding sites in the MIP.
Release of S-propanolol from disulde-based MIP nanogels
MIPs have particular release properties compared to other drug delivery systems due to their specic molecular recognition. 34 In order to explore the potential application of these redoxsensible MIPs as intracellular drug delivery system, the effect of the polymer network cleavage under physiological reductive environment on the drug release properties have been examined. Indeed, the degradation of the polymer network is one of the possible release mechanisms of the encapsulated molecule in drug delivery systems. 35 The release experiment was performed with 10 mM GSH in sodium acetate buffer (pH 5.0, 0.1 M), since this pH and GSH concentration are usually found in endosomes and lysosomes. 13, 36 First, we investigated the release of the 8-anilino-1naphthalenesulfonic acid (ANS) uorescent dye from a uotagged DSDMA-based polymer. Indeed, ANS is a solvatochromic dye, sensitive to polarity change of the environment. It exhibits a decrease in quantum yield accompanied by a red shi of uorescence maximum as the polarity of the solvent increases. 37 Thus the release of ANS can be monitored directly by spectrouorimetry. ANS uo-tagged DSDMA-based polymer nanogels were synthesized by free radical polymerization using the same formulation as for the MIP nanogels, without the template (see ESI †). Fluo-tagged nanogels with 28 nm particles size have been obtained. The cytotoxicity of these particles was estimated on HaCat cells by in vitro MTT assays (see ESI Fig. S4 †) . No cytotoxicity for DSDMA-based particles were observed up to the concentration of 200 mg L À1 , suggesting the low toxicity of these nanogels. This result indicates that DSDMA-based nanogel could be a promising pharmaceuticals carrier. The nanogels' uorescence spectrum and the release of ANS from DSDMA cross-linked nanogels with or without addition of GSH in the medium are presented in Fig. S5 (ESI †) . Aer 96 h incubation, only 30% ANS was released from DSDMA-based nanogel in a media without GSH, while the released amount of ANS was 51% in the presence of 10 mM GHS. The release of ANS from the nanogels is accelerated in the presence of GSH due to the cleavage of the disulde bonds in the polymer network, thus facilitating the diffusion of ANS within the nanogels. The effect of the polymer network cleavage on the MIP release properties was then examined under physiological reductive environment. For this purpose, DSDMA-based MIP and NIP nanogels were rst incubated with S-propranolol (0.59 mg adsorbed S-propranolol per mg MIP, 0.51 mg adsorbed S-propranolol per mg NIP), then release experiments of Spropranolol from the nanogels in the presence/absence of GSH were carried out by a dialysis method (Fig. 6 ). Without GSH, the S-propranolol release from NIP or MIP reached an equilibrium aer 2 h with a maximum amount of S-propranolol released of 33% and 22% from NIP and MIP, respectively, and no-burst effect was observed. The S-propranolol release from NIP is faster and higher than from MIP (1.7 and 1.5 times, respectively). This may be explained by the lower affinity of S- propranolol for the NIP. In the presence of GSH, the amount of S-propranolol released from MIP and the release rate were increased by 1.5 and 2 times, respectively, due to the degradation of the polymer network. More interestingly, the amount released at the end was comparable with NIP, which conrms the loss of molecular recognition of MIP when reducing agent was present. S-Propanolol release from MIP and NIP were also tted by the Peppas model 38 to study the release mechanism (see ESI Table S1 †). The release exponent n was determined to be 0.44, 0.87 and 0.52, respectively for NIP, MIP and MIP in presence of GSH, suggesting clearly different release mechanisms between these systems. These results indicated that DSDMA cross-linked MIP permits control over the drug delivery with a limited release of the drug under physiological condition as in bloodstream but triggered a rapid and sustained drug release in reductive environment as the one found in cells or in tumor tissues. Thus, reduction-responsive molecularly imprinted polymers are promising materials as an intracellular drug delivery system.
Conclusion
Reduction-responsive molecularly imprinted polymers were synthesized by using a disulde-containing cross-linker, which can be cleaved in a reductive environment. Different forms of reduction-responsive MIPs were synthesized with size ranges from 30 nm to 2 mm. The reduction-responsive MIPs demonstrate similar or even better binding property for a b-blocker (Spropranolol) compared to conventional MIPs synthesized using the cross-linker EDMA. In a reductive environment, disulde bonds can be cleaved to produce less cross-linked materials and thus induce morphological and chemical modication, associated with the modulated binding and the release of template molecules. This suggests the possibility of this reductionresponsive MIPs being used for intracellular drug delivery applications.
